CREDIT SUISSE AG/ - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2022$1,426,891
-49.3%
1,347,000
-50.9%
0.00%0.0%
Q3 2021$2,816,000
+363.9%
2,741,000
+356.8%
0.00%
Q1 2021$607,000
-91.2%
600,000
-90.6%
0.00%
-100.0%
Q4 2020$6,864,000
+66.7%
6,396,000
+63.0%
0.00%0.0%
Q3 2020$4,118,000
-30.5%
3,924,000
-19.0%
0.00%
-25.0%
Q2 2020$5,921,000
+104.2%
4,845,000
+75.1%
0.00%
+33.3%
Q1 2020$2,900,000
-28.2%
2,767,000
-27.6%
0.00%0.0%
Q4 2019$4,039,000
+116.1%
3,823,000
+112.4%
0.00%
+50.0%
Q2 2019$1,869,000
-41.1%
1,800,000
-41.9%
0.00%
-33.3%
Q1 2019$3,172,000
-3.3%
3,100,000
-6.1%
0.00%0.0%
Q4 2018$3,281,000
-51.1%
3,300,000
-47.6%
0.00%
-50.0%
Q3 2018$6,714,000
+32.9%
6,300,000
+26.0%
0.01%
+20.0%
Q2 2018$5,051,000
-12.7%
5,000,000
-18.9%
0.01%0.0%
Q1 2018$5,786,000
+45.2%
6,163,000
+54.1%
0.01%
+25.0%
Q4 2017$3,985,000
+22.2%
4,000,000
+24.2%
0.00%
+33.3%
Q3 2017$3,262,0003,220,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 30,138,000$29,510,0003.72%
PFM Health Sciences, LP 45,910,000$46,002,0001.72%
Cheyne Capital Management (UK) LLP 2,320,000$2,330,0001.47%
ADVENT CAPITAL MANAGEMENT /DE/ 41,077,000$41,277,0000.66%
SSI INVESTMENT MANAGEMENT LLC 9,071,000$9,068,0000.50%
PALISADE CAPITAL MANAGEMENT, LP 14,548,000$14,612,0000.34%
RWC Asset Management LLP 7,500,000$7,552,0000.21%
KBC Group NV 400,000$40,316,0000.15%
PROSPECTOR PARTNERS LLC 1,000,000$1,000,0000.12%
MACKAY SHIELDS LLC 11,822,000$11,816,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders